e-learning
resources
Monograph
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
In vitro
and
in vivo
laboratory models of pleural disease
Xuan Yao, Nikolaos I. Kanellakis
Source:
Eur Respir Monogr 2020; 87: 29-47
Journal Issue:
Pleural Disease
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Xuan Yao, Nikolaos I. Kanellakis.
In vitro
and
in vivo
laboratory models of pleural disease. Eur Respir Monogr 2020; 87: 29-47
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Definition and history of sarcoidosis
Related content which might interest you:
Pulmonary mechanics in a mouse model of emphysema: in vivo and in vitro evaluation
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008
Development of
in vitro
assays to predict fibrogenesis and replace animal testing
Source: Eur Respir J 2006; 28: Suppl. 50, 521s
Year: 2006
In vitro and in vivo studies of nanoparticles and the lung
Source: International Congress 2014 – Nanomaterials and respiratory health
Year: 2014
Rapid diagnosis of tuberculosis using ex vivo host biomarkers in sputum
Source: Eur Respir J 2014; 44: 254-257
Year: 2014
3he MRI and an animal model of interstitial lung disease
Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities
Year: 2009
Clinically validated markers of the extracellular matrix remodelling are altered by potential anti-fibrotic compounds in a human lung fibrosis ex vivo model
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Year: 2018
Molecular imaging of the progression of pulmonary fibrosis using animal models of disease
Source: Eur Respir J 2006; 28: Suppl. 50, 605s
Year: 2006
Modeling in vitro, ex vivo or in vivo?
Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development
Year: 2013
In vitro modelling of epithelia-fibroblast interactions in idiopathic pulmonary fibrosis
Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease
Year: 2019
In vivo imaging of NF-kB pathway in acute lung inflammation mouse model can predict a pharmacological response
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011
PG19 In vitro models of the pulmonary epithelium: beyond simple culture
Source: Milan 2017 - Educational material
Year: 2017
LPA1 antagonist BMS-986278 for idiopathic pulmonary fibrosis: Preclinical pharmacological in vitro and in vivo evaluation
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2019
Precision cut lung slices from bleomycin challenged mice – ex vivo model for testing novel therapies for lung fibrosis
Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease
Year: 2019
An
in vivo
comparison of two lung function systems
Source: Eur Respir J 2005; 26: Suppl. 49, 177s
Year: 2005
Computed-tomography-based radiomics features for staging of interstitial lung disease – transferability from experimental to human lung fibrosis - a proof-of-concept study
Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update
Year: 2019
Progress in modelling acute lung injury in a pre-clinical mouse model
Source: Eur Respir J 2012; 39: 1062-1063
Year: 2012
Preclinical models and imaging biomarkers of lung injury and disease
Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease
Year: 2021
Characterization of human airway epithelial cell lines as in vitro models of chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021
Late Breaking Abstract - Development of an ex vivo pediatric preclinical model of bronchopulmonary dysplasia for aerosol regional deposition studies
Source: International Congress 2018 – New pharmacological strategies in airway diseases
Year: 2018
Studying the biological properties of pleural fluid: pleural fluid alone is adequate for cancer cell proliferation in vitro
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept